• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » China to cut red tape on imports of medical devices, medicine

China to cut red tape on imports of medical devices, medicine

December 19, 2014 By MassDevice Contributors Network

China to cut red tape on imports of medical devices, medicine

(Reuters) — China agreed to allow U.S. medical devices and medicines into local markets more quickly and open up its anti-trust procedures, U.S. Commerce Secretary Penny Pritzker said yesterday after bilateral trade talks between the 2 nations.

U.S. and Chinese officials said they made progress on a range of issues at a 3-day Joint Commission on Commerce and Trade meeting, which aims to smooth out snags in a trade relationship worth more than $600 billion a year.

The U.S. side highlighted progress on intellectual property and anti-trust laws as well as opening markets for U.S. products such as medical devices and medicines, which firms have complained are subject to a burdensome approval process.

"They agreed to cut red tape for imports of new and innovative pharmaceuticals and medical devices and to deal with the backlog," Pritzker told reporters.

China agreed to publish the results of administrative proceedings conducted under its anti-monopoly laws and allow U.S. firms to consult with legal counsel, she said. China’s laws have been criticized for lacking transparency and targeting foreign companies.

In a press conference in Chicago prior to the U.S. announcement, Chinese officials did not comment on medical devices and medicines. They said, however, that both sides agreed on "intensifying cooperation on food safety."

U.S. trade representative Michael Froman said the 2 countries agreed to talk more about approvals for biotech crops, which seed companies have complained take too long and are often not based on science.

As the talks began, China said it would approve imports of American-grown Viptera corn developed by Swiss-based Syngenta, as well as shipments of biotech soybeans developed by DuPont Pioneer and Bayer CropScience.

"The dialogue we’ve agreed to, to ease the adoption of our innovative agricultural products, will benefit corn and soybean farmers right here in America’s heartland," Froman said.

Niu Dun, China’s vice minister of agriculture, said through a translator: "The regulation [and] supervision of biotechnology products is a priority in China-U.S. cooperation and we are making smooth progress."

Pritzker said the 2 countries also had productive talks on how to deal with excess capacity in the solar industry, after the United States slapped hefty anti-dumping and anti-subsidy duties on Chinese solar goods as the talks began.

Filed Under: News Well, Wall Street Beat Tagged With: Exports, U.S. Commerce Dept.

More recent news

  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy